Seronegative autoimmune diseases: A challenging diagnosis

Marco Vincenzo Lenti(University of Pavia), Antonio Di Sabatino(University of Pavia), Mario Rotondi(University of Pavia), Paola Bianchi(University of Pavia), Luca Chiovato, Serena Bugatti, Federica Melazzini(University of Pavia), Carlo Maria Rossi(University of Pavia), Gino Roberto Corazza(University of Pavia), Matteo Gastaldi(Fondazione Istituto Neurologico Nazionale Casimiro Mondino), Antonella Gentile(University of Pavia), Carlomaurizio Montecucco(University of Pavia)

Autoimmunity Reviews

July 15, 2022

10.1016/j.autrev.2022.103143

Cited by 87

Related Papers

PAX8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis

|Nature Genetics|1998|502

Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial

|The Lancet|2021|315

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial

|Nature Medicine|2022|277

World Gastroenterology Organisation Global Guidelines on Celiac Disease

|Journal of Clinical Gastroenterology|2013|266

Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): Rationale and feasibility of a shared pragmatic protocol

|Nutrition|2020|264